UNITY BIOTECHNOLOGY INC (UBX) Stock Balance Sheet
NASDAQ:UBX - Nasdaq - US91381U2006 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 7.58M | 19.80M | 12.74M | 32.91M | 17.81M | |||
| Marketable Securities | 15.65M | 23.40M | 82.06M | 55.17M | 79.89M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.04M | 3.40M | 1.74M | 2.43M | 3.17M | |||
| Total Current Assets | 24.27M | 46.60M | 96.53M | 90.50M | 100.87M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.36M | 18.06M | 26.87M | 31.23M | 36.14M | |||
| Investments And Advances | N/A | N/A | 0.00 | 1.99M | 17.87M | |||
| Other Non-Current Assets | 1.04M | 1.02M | 948.00K | 987.00K | 1.45M | |||
| Total Non-Current Assets | 13.39M | 19.09M | 27.82M | 34.21M | 55.45M | |||
| TOTAL ASSETS | 37.66M | 65.69M | 124.35M | 124.71M | 156.32M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 9.48M | 3.06M | 0.00 | |||
| Accrued Expenses | 8.26M | 6.46M | 8.35M | 10.40M | 11.90M | |||
| Accounts Payable | 997.00K | 1.38M | 1.79M | 1.99M | 2.56M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 1.18M | 0.00 | |||
| Total Current Liabilities | 9.26M | 7.84M | 19.62M | 16.62M | 14.46M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 10.89M | 18.41M | 24.51M | |||
| Other Non-Current Liabilities | 21.91M | 29.45M | 37.76M | 30.12M | 34.47M | |||
| Total Non-Current Liabilities | 21.91M | 29.45M | 48.65M | 48.53M | 58.98M | |||
| TOTAL LIABILITIES | 31.17M | 37.29M | 68.27M | 65.14M | 73.44M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -510.34M | -484.35M | -444.49M | -400.02M | -339.30M | |||
| Additional Paid In Capital | 516.82M | 512.77M | 500.83M | 459.63M | 422.38M | |||
| Common Shares | 2.00K | 2.00K | 1.00K | 6.00K | 5.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 0.00 | -210.00K | |||
| Shares Outstanding | 16.86M | 16.79M | 14.21M | 6.30M | 5.33M | |||
| Tangible Book Value per Share | 0.39 | 1.69 | 3.95 | 9.46 | 15.56 | |||
| Total Shareholders' Equity | 6.49M | 28.40M | 56.08M | 59.57M | 82.88M | |||
| TOTAL LIABILITIES AND EQUITY | 37.66M | 65.69M | 124.35M | 124.71M | 156.32M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.19 | 0.31 | 0.30 | |||
| Current Ratio | 2.62 | 5.94 | 4.92 | 5.45 | 6.97 | |||
| Return On Assets (ROA) | -69.01% | -60.68% | -35.76% | -48.69% | -60.03% | |||
| Return On Equity (ROE) | -400.22% | -140.36% | -79.29% | -101.94% | -113.23% | |||
All data in USD , ROIC based on taxRate of 0.21